CFTR and cystic fibrosis: ,52 However, considering CF, off-label prescription of the currently available CFTR modulators is possible in some but not all countries, and a lack of indication may allow third-party payers (e.g., health insurance companies and local health authority funders) to deny access regardless of the efficacy proven by tests in vitro.